Morgan Stanley Maintains Underweight on Helmerich & Payne, Raises Price Target to $39
Helmerich & Payne, Inc.
Helmerich & Payne, Inc. HP | 0.00 |
Morgan Stanley analyst Daniel Kutz maintains Helmerich & Payne (NYSE:
HP) with a Underweight and raises the price target from $35 to $39.